214 related articles for article (PubMed ID: 20638903)
1. Tumor-stromal cell interactions and opportunities for therapeutic intervention.
Udagawa T; Wood M
Curr Opin Pharmacol; 2010 Aug; 10(4):369-74. PubMed ID: 20638903
[TBL] [Abstract][Full Text] [Related]
2. Biomechanical forces shape the tumor microenvironment.
Shieh AC
Ann Biomed Eng; 2011 May; 39(5):1379-89. PubMed ID: 21253819
[TBL] [Abstract][Full Text] [Related]
3. Modulating the tumor microenvironment with RNA interference as a cancer treatment strategy.
Zins K; Sioud M; Aharinejad S; Lucas T; Abraham D
Methods Mol Biol; 2015; 1218():143-61. PubMed ID: 25319650
[TBL] [Abstract][Full Text] [Related]
4. Cancer-associated-fibroblasts and tumour cells: a diabolic liaison driving cancer progression.
Cirri P; Chiarugi P
Cancer Metastasis Rev; 2012 Jun; 31(1-2):195-208. PubMed ID: 22101652
[TBL] [Abstract][Full Text] [Related]
5. Targeting stromal-cancer cell interactions with siRNAs.
Aharinejad S; Sioud M; Lucas T; Abraham D
Methods Mol Biol; 2009; 487():243-66. PubMed ID: 19301651
[TBL] [Abstract][Full Text] [Related]
6. Tumor-host interactions: a far-reaching relationship.
McAllister SS; Weinberg RA
J Clin Oncol; 2010 Sep; 28(26):4022-8. PubMed ID: 20644094
[TBL] [Abstract][Full Text] [Related]
7. Mesenchymal stem cell-derived interleukin-6 and vascular endothelial growth factor promote breast cancer cell migration.
De Luca A; Lamura L; Gallo M; Maffia V; Normanno N
J Cell Biochem; 2012 Nov; 113(11):3363-70. PubMed ID: 22644871
[TBL] [Abstract][Full Text] [Related]
8. Hallmarks of cancer: interactions with the tumor stroma.
Pietras K; Ostman A
Exp Cell Res; 2010 May; 316(8):1324-31. PubMed ID: 20211171
[TBL] [Abstract][Full Text] [Related]
9. Tumor-stromal interactions in lung cancer: novel candidate targets for therapeutic intervention.
El-Nikhely N; Larzabal L; Seeger W; Calvo A; Savai R
Expert Opin Investig Drugs; 2012 Aug; 21(8):1107-22. PubMed ID: 22667993
[TBL] [Abstract][Full Text] [Related]
10. [Tumor-stroma interactions].
Billottet C; Jouanneau J
Bull Cancer; 2008 Jan; 95(1):51-6. PubMed ID: 18230570
[TBL] [Abstract][Full Text] [Related]
11. Induction of hepatocyte growth factor in fibroblasts by tumor-derived factors affects invasive growth of tumor cells: in vitro analysis of tumor-stromal interactions.
Nakamura T; Matsumoto K; Kiritoshi A; Tano Y; Nakamura T
Cancer Res; 1997 Aug; 57(15):3305-13. PubMed ID: 9242465
[TBL] [Abstract][Full Text] [Related]
12. Vascular targeting therapy: potential benefit depends on tumor and host related effects.
Horsman MR; Bohn AB; Busk M
Exp Oncol; 2010 Sep; 32(3):143-8. PubMed ID: 21403608
[TBL] [Abstract][Full Text] [Related]
13. Tumor and stromal pathways mediating refractoriness/resistance to anti-angiogenic therapies.
Crawford Y; Ferrara N
Trends Pharmacol Sci; 2009 Dec; 30(12):624-30. PubMed ID: 19836845
[TBL] [Abstract][Full Text] [Related]
14. Cancer. Encouraging results for second-generation antiangiogenesis drugs.
Marx J
Science; 2005 May; 308(5726):1248-9. PubMed ID: 15919970
[No Abstract] [Full Text] [Related]
15. Stromagenesis: the changing face of fibroblastic microenvironments during tumor progression.
Beacham DA; Cukierman E
Semin Cancer Biol; 2005 Oct; 15(5):329-41. PubMed ID: 15970443
[TBL] [Abstract][Full Text] [Related]
16. Tumor-lymphatic interactions in an activated stromal microenvironment.
Wong SY; Hynes RO
J Cell Biochem; 2007 Jul; 101(4):840-50. PubMed ID: 17177186
[TBL] [Abstract][Full Text] [Related]
17. VEGF-null cells require PDGFR alpha signaling-mediated stromal fibroblast recruitment for tumorigenesis.
Dong J; Grunstein J; Tejada M; Peale F; Frantz G; Liang WC; Bai W; Yu L; Kowalski J; Liang X; Fuh G; Gerber HP; Ferrara N
EMBO J; 2004 Jul; 23(14):2800-10. PubMed ID: 15229650
[TBL] [Abstract][Full Text] [Related]
18. Role of the host stroma in cancer and its therapeutic significance.
Tarin D
Cancer Metastasis Rev; 2013 Dec; 32(3-4):553-66. PubMed ID: 23625010
[TBL] [Abstract][Full Text] [Related]
19. Tumor microenvironment: the role of the tumor stroma in cancer.
Li H; Fan X; Houghton J
J Cell Biochem; 2007 Jul; 101(4):805-15. PubMed ID: 17226777
[TBL] [Abstract][Full Text] [Related]
20. Redefining the target again: chemotherapeutics as vascular disrupting agents?
Gokmen-Polar Y; Miller KD
Cancer Cell; 2008 Sep; 14(3):195-6. PubMed ID: 18772108
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
